We examined DNAm profiles of peripheral blood mononuclear cells of PMF patients with JAK2 V617F mutation (n = 10), CALR mutation (n = 10), MPL mutation (n = 10, including two ET samples), alongside healthy controls (n = 10; Supplemental Table S1). This evidence concerns the gene JAK2 and essential thrombocythemia.